AU7690794A - Acylpyrrole-alkanoic acids and indole-2-alkanoic acids plus their derivatives for use as inhibitors of phospholipase a2 - Google Patents
Acylpyrrole-alkanoic acids and indole-2-alkanoic acids plus their derivatives for use as inhibitors of phospholipase a2Info
- Publication number
- AU7690794A AU7690794A AU76907/94A AU7690794A AU7690794A AU 7690794 A AU7690794 A AU 7690794A AU 76907/94 A AU76907/94 A AU 76907/94A AU 7690794 A AU7690794 A AU 7690794A AU 7690794 A AU7690794 A AU 7690794A
- Authority
- AU
- Australia
- Prior art keywords
- alkanoic acids
- acylpyrrole
- phospholipase
- indole
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002253 acid Substances 0.000 title 2
- 150000007513 acids Chemical class 0.000 title 2
- 102100037611 Lysophospholipase Human genes 0.000 title 1
- 108010058864 Phospholipases A2 Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/99—Enzyme inactivation by chemical treatment
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19934338770 DE4338770A1 (en) | 1993-11-12 | 1993-11-12 | Indole-2-alkanoic acids and their derivatives as inhibitors of phospholipase A¶2¶ |
| DE4338770 | 1993-11-12 | ||
| PCT/DE1994/001121 WO1995013266A1 (en) | 1993-11-12 | 1994-09-20 | Acylpyrrole-alkanoic acids and indole-2-alkanoic acids plus their derivatives for use as inhibitors of phospholipase a¿2? |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7690794A true AU7690794A (en) | 1995-05-29 |
Family
ID=6502508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU76907/94A Abandoned AU7690794A (en) | 1993-11-12 | 1994-09-20 | Acylpyrrole-alkanoic acids and indole-2-alkanoic acids plus their derivatives for use as inhibitors of phospholipase a2 |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU7690794A (en) |
| DE (1) | DE4338770A1 (en) |
| WO (1) | WO1995013266A1 (en) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE255090T1 (en) * | 1996-08-01 | 2003-12-15 | Merckle Gmbh | ACYLPYRROLDICARBONONIC ACIDS AND ACYLINDOLICARBONONIC ACIDS AND THEIR DERIVATIVES AS INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 |
| US6630496B1 (en) | 1996-08-26 | 2003-10-07 | Genetics Institute Llc | Inhibitors of phospholipase enzymes |
| US6569539B2 (en) | 1996-10-30 | 2003-05-27 | Tetra Level Holdings & Finance S.A. | Gas barrier packaging laminate method for production thereof and packaging containers |
| TR200002446T2 (en) * | 1998-02-25 | 2000-12-21 | Genetics Institute, Inc. | Inhibitors of phospholipase enzymes |
| US6828344B1 (en) | 1998-02-25 | 2004-12-07 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| AU3297099A (en) * | 1998-02-25 | 1999-09-15 | Genetics Institute Inc. | Inhibitors of phospholipase a2 |
| US6916841B2 (en) | 1998-02-25 | 2005-07-12 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| BR9908275A (en) * | 1998-02-25 | 2000-10-24 | Genetics Inst | Phospholipase enzyme inhibitors |
| US6500853B1 (en) | 1998-02-28 | 2002-12-31 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| KR20030036917A (en) | 2000-10-10 | 2003-05-09 | 스미스클라인 비참 코포레이션 | SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-γBINDING AGENTS |
| DK1397130T3 (en) | 2001-06-20 | 2007-11-12 | Wyeth Corp | Substituted Indole Acid Derivatives as Inhibitors of Plasminogen Activator Inhibitor-1 (PAI-1) |
| TWI224101B (en) | 2001-06-20 | 2004-11-21 | Wyeth Corp | Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| CA2461670A1 (en) | 2001-09-27 | 2003-04-10 | F. Hoffmann-La Roche Ag | Indole derivatives as cox ii inhibitors |
| US7101875B2 (en) | 2001-12-03 | 2006-09-05 | Wyeth | Methods for treating arthritic disorders |
| US6635771B2 (en) | 2001-12-03 | 2003-10-21 | Wyeth | N-benzhydryl indole compounds |
| US7713964B2 (en) | 2001-12-03 | 2010-05-11 | Wyeth Llc | Methods for treating asthmatic conditions |
| US6984735B2 (en) | 2001-12-03 | 2006-01-10 | Wyeth | Process for making an aldehyde |
| US6797708B2 (en) | 2001-12-03 | 2004-09-28 | Wyeth | Inhibitors of cytosolic phospholipase A2 |
| US7605156B2 (en) | 2001-12-03 | 2009-10-20 | Wyeth | Methods for the use of inhibitors of cytosolic phospholipase A2 |
| JP2006514637A (en) | 2002-12-10 | 2006-05-11 | ワイス | Substituted 3-carbonyl-1H-indol-1-ylacetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| DE60324183D1 (en) | 2002-12-10 | 2008-11-27 | Wyeth Corp | Aryl-, aryloxy- und alkyloxysubstituierte 1h-indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1) |
| DK1569899T3 (en) | 2002-12-10 | 2006-10-23 | Wyeth Corp | Substituted 3-alkyl and 3-arylalkyl-1H-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| ATE430731T1 (en) | 2002-12-10 | 2009-05-15 | Wyeth Corp | SUBSTITUTED INDOLOXOACETYLAMINOACETIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) |
| UA80453C2 (en) | 2002-12-10 | 2007-09-25 | Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
| US7351726B2 (en) | 2003-09-25 | 2008-04-01 | Wyeth | Substituted oxadiazolidinediones |
| US7446201B2 (en) | 2003-09-25 | 2008-11-04 | Wyeth | Substituted heteroaryl benzofuran acids |
| US7141592B2 (en) | 2003-09-25 | 2006-11-28 | Wyeth | Substituted oxadiazolidinediones |
| US7534894B2 (en) | 2003-09-25 | 2009-05-19 | Wyeth | Biphenyloxy-acids |
| US7442805B2 (en) | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
| US7268159B2 (en) | 2003-09-25 | 2007-09-11 | Wyeth | Substituted indoles |
| US7411083B2 (en) | 2003-09-25 | 2008-08-12 | Wyeth | Substituted acetic acid derivatives |
| US7163954B2 (en) | 2003-09-25 | 2007-01-16 | Wyeth | Substituted naphthyl benzothiophene acids |
| US7582773B2 (en) | 2003-09-25 | 2009-09-01 | Wyeth | Substituted phenyl indoles |
| US7265148B2 (en) | 2003-09-25 | 2007-09-04 | Wyeth | Substituted pyrrole-indoles |
| US7342039B2 (en) | 2003-09-25 | 2008-03-11 | Wyeth | Substituted indole oximes |
| US7420083B2 (en) | 2003-09-25 | 2008-09-02 | Wyeth | Substituted aryloximes |
| US7332521B2 (en) | 2003-09-25 | 2008-02-19 | Wyeth | Substituted indoles |
| BRPI0514544A (en) | 2004-08-23 | 2008-06-17 | Wyeth Corp | oxazol-naphthyl acids as modulators of plasminogen activator inhibitor type-1 (pai-1) |
| US7186749B2 (en) | 2004-08-23 | 2007-03-06 | Wyeth | Pyrrolo-naphthyl acids and methods for using them |
| CN101044127A (en) | 2004-08-23 | 2007-09-26 | 惠氏公司 | Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1 |
| TW200718687A (en) | 2005-05-27 | 2007-05-16 | Wyeth Corp | Inhibitors of cytosolic phospholipase A2 |
| WO2007022321A2 (en) | 2005-08-17 | 2007-02-22 | Wyeth | Substituted indoles and use thereof |
| GB2431927B (en) * | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
| US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
| US8399666B2 (en) | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
| TW200920369A (en) | 2007-10-26 | 2009-05-16 | Amira Pharmaceuticals Inc | 5-lipoxygenase activating protein (flap) inhibitor |
| MX2010012814A (en) | 2008-05-23 | 2010-12-20 | Amira Pharmaceuticals Inc | 5-lipoxygenase-activating protein inhibitor. |
| US8546431B2 (en) | 2008-10-01 | 2013-10-01 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
| RU2012136451A (en) | 2010-01-28 | 2014-03-10 | Президент Энд Феллоуз Оф Гарвард Колледж | COMPOSITIONS AND METHODS FOR IMPROVING PROTEASOMIC ACTIVITY |
| HRP20190867T1 (en) | 2011-05-12 | 2019-07-12 | Proteostasis Therapeutics, Inc. | Proteostasis regulators |
| WO2014116228A1 (en) | 2013-01-25 | 2014-07-31 | President And Fellows Of Harvard College | Usp14 inhibitors for treating or preventing viral infections |
| WO2015073528A1 (en) | 2013-11-12 | 2015-05-21 | Proteostasis Therapeutics, Inc. | Proteasome activity enhancing compounds |
| SI3860998T1 (en) | 2018-10-05 | 2024-06-28 | Annapurna Bio Inc. | Compounds and compositions for treating conditions associated with apj receptor activity |
| FI4426434T3 (en) | 2021-11-02 | 2025-11-24 | Flare Therapeutics Inc | Pparg inverse agonists and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4396626A (en) * | 1980-10-09 | 1983-08-02 | Beecham Group Limited | Cyclic compounds and their use |
| US4560699A (en) * | 1983-01-17 | 1985-12-24 | Syntex (U.S.A.) Inc. | 5-(4-Vinylbenzoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]-pyrrole-1-carboxylic acids and derivatives thereof and use as analgesics and anti-inflammatories |
| US4792555A (en) * | 1987-03-20 | 1988-12-20 | American Home Products Corporation | Phospholipase A2 inhibitors |
| FR2641464B1 (en) * | 1989-01-06 | 1994-06-03 | Rolland Sa A | NOVEL PHARMACEUTICAL COMPOSITIONS EXPRESSING INHIBITORY PROPERTIES WITH RESPECT TO PHOSPHOLIPASE A2 |
| DE3915450A1 (en) * | 1989-05-11 | 1990-11-15 | Gerd Prof Dr Dannhardt | SUBSTITUTED PYRROL COMPOUNDS AND THEIR USE IN PHARMACY |
| PT95692A (en) * | 1989-10-27 | 1991-09-13 | American Home Prod | PROCESS FOR THE PREPARATION OF INDOLE-, INDENO-, PYRANOINDOLE- AND TETRA-HYDROCARBAZOLE-ALCANOIC ACID DERIVATIVES, OR WHICH ARE USEFUL AS PLA2 INHIBITORS AND LIPOXIGENASE |
| US5081145A (en) * | 1990-02-01 | 1992-01-14 | Merck Frosst Canada, Inc. | Indole-2-alkanoic acids compositions of and anti allergic use thereof |
-
1993
- 1993-11-12 DE DE19934338770 patent/DE4338770A1/en not_active Ceased
-
1994
- 1994-09-20 AU AU76907/94A patent/AU7690794A/en not_active Abandoned
- 1994-09-20 WO PCT/DE1994/001121 patent/WO1995013266A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995013266A1 (en) | 1995-05-18 |
| DE4338770A1 (en) | 1995-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7690794A (en) | Acylpyrrole-alkanoic acids and indole-2-alkanoic acids plus their derivatives for use as inhibitors of phospholipase a2 | |
| AU6178894A (en) | Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase | |
| AU7168696A (en) | Inhibitors of regulatory pathways | |
| PL337698A1 (en) | Derivatives of 4-bromo- or iodo-phenylaminobenzhydroxamic acid and their application as mek inhibitors | |
| AU5621594A (en) | 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 | |
| PL327185A1 (en) | Thyrosine derivatives as inhibitors of integrin-alpha v | |
| AU4267293A (en) | Use of MMP inhibitors | |
| AU6174696A (en) | Inhibitors of phospholipase a2 | |
| AU5575294A (en) | Plaster for testing and method of testing | |
| AU4159197A (en) | Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases | |
| AU5886296A (en) | Heterocyclo substituted hydroxamic acid derivatives as cyclo oxygenase-2 and 5-lipoxygenase inhibitors | |
| AU4640496A (en) | Boronic acid and ester inhibitors of thrombin | |
| AU4669493A (en) | Indole and indene derivatives as pla2 and lipoxygenase inhibitors | |
| AU5493598A (en) | N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases | |
| AU5722796A (en) | Cyclobutane derivatives and their use as inhibitors of prote in farnesyltransferase | |
| AU6157396A (en) | Bis-arylsulfonylaminobenzamide derivatives and the use there of as factor xa inhibitors | |
| PL322549A1 (en) | Inhibitors of proteinous farnesiltransferase | |
| AU7294194A (en) | Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof | |
| AU8140898A (en) | Inhibitors of beta-lactamases and uses therefor | |
| AU4024295A (en) | Amino acid derivatives of paclitaxel | |
| AU3612895A (en) | Purine and guanine compounds as inhibitors of pnp | |
| AU2228292A (en) | Peptide derivatives of collagenase inhibitor | |
| AU631201B2 (en) | Corrosion inhibitor and method of use | |
| AU3820597A (en) | Phosphatase inhibitors and methods of use thereof | |
| AU3734999A (en) | Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |